Menlo Park, CA, United States of America

Ehesan U I Sharif

This inventor holds 1 USPTO granted patent. Top assignee: Arcus Biosciences, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ehesan U I Sharif. Retrieved from https://idiyas.com/inventor/ehesan-u-i-sharif

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ehesan U I Sharif: Innovator in Pharmaceutical Research

Introduction

Ehesan U I Sharif is a notable inventor based in Menlo Park, CA. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target adenosine receptors. His work is crucial in addressing various diseases and disorders.

Latest Patents

Ehesan holds a patent for Pyridone A2R antagonists. This compound inhibits at least one of the A and A adenosine receptors. The patent describes compositions containing the compound and methods for synthesizing it. Additionally, it outlines the use of such compounds for treating a diverse array of diseases, including cancer- and immune-related disorders mediated by the adenosine receptors.

Career Highlights

Ehesan is currently associated with Arcus Biosciences, Inc., where he continues to innovate in the pharmaceutical sector. His research focuses on developing new therapeutic strategies that can significantly impact patient care.

Collaborations

Ehesan collaborates with talented professionals in his field, including Manmohan Reddy Leleti and Debashis Mandal. These collaborations enhance the research and development efforts at Arcus Biosciences, Inc.

Conclusion

Ehesan U I Sharif is a prominent figure in pharmaceutical innovation, with a focus on adenosine receptor antagonists. His contributions are paving the way for new treatments for complex diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…